Edwards Lifesciences Corporation (EW) : The money flow analysis of Edwards Lifesciences Corporation (EW) indicates a $17.27 million of outflow was on downticks, whereas, the investors on Wednesday gobbled up stocks worth $26.37 million on upticks. The ratio between the upticks and downticks was clearly in favor of the bulls at 1.53 and so was the total money flow at $9.1 million. A solid up-down ratio of 7.05 in block trades indicates that the investors are accumulating the stock on weakness. The bulls lapped up $9.41 million worth of block trades on upticks. Only $1.34 million worth of the stock exchanged hands on downticks. The money flow was $8.07 million in block trades, underlining the interest of the bulls in the stock even when the stock was declining.However, the price action shows that the bears had an upper hand in the stock of Edwards Lifesciences Corporation (EW), pushing it down by -0.63% for the day. The stock slid $0.76 and traded at $120.46 during the day. Nonetheless, the stock is 0.58% over the previous weeks close.
Shares of Edwards Lifesciences Corp. rose by 1.08% in the last five trading days and 3.76% for the last 4 weeks. Edwards Lifesciences Corp. is up 24.3% in the last 3-month period. Year-to-Date the stock performance stands at 52.52%.
Edwards Lifesciences Corporation (EW) : 11 brokerage houses believe that Edwards Lifesciences Corporation (EW) is a Strong Buy at current levels. 1 Analyst considers the fundamentals to be worthy of a Buy recommendation. 4 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Edwards Lifesciences Corporation (EW). Zacks Investment Research suggests a Buy with a rank of 2.The median of all the 16 Wall Street Analysts endorse the stock as a Buy with a rating of 1.53.
Edwards Lifesciences Corporation (NYSE:EW): stock was range-bound between the intraday low of $119.72 and the intraday high of $121.3 after having opened at $121.08 on Wednesdays session. The stock finally closed in the red at $121.08, a loss of -0.63%. The stock remained in the red for the whole trading day. The total traded volume was 676,085 shares. The stock failed to cross $121.3 in Wednesdays trading. The stocks closing price on Thursday was $121.22.
Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. It is a manufacturer of heart valve systems and repair products used to replace or repair a patients diseased or defective heart valve. The Company develops hemodynamic monitoring systems used to measure a patients cardiovascular function in the hospital setting. Patients in the hospital setting, including high-risk patients in the operating room or intensive care unit, are candidates for having their cardiac function or fluid levels monitored by the its Critical Care products. The Companys products and technologies it offers to treat advanced cardiovascular disease are categorized into three main areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care.